Skip to main content
Premium Trial:

Request an Annual Quote

Accuri Closes $13M Series C Financing

NEW YORK (GenomeWeb News) - Accuri Cytometers said today that it has closed a $13 million Series C financing round led by Fidelity Biosciences and Flagship Ventures.
Current investors including Baird Venture Partners and Arboretum Ventures also participated in the financing.
Accuri said it will use the proceeds to expand marketing and sales activities for its Accuri C6 Flow Cytometer System, a benchtop cell analysis system that is a “fraction of the cost” of comparable flow cytometers, according to the company.  
Concurrent with the financing, Bahaa Fam, a venture partner with Fidelity Biosciences, and Harry Wilcox, a partner at Flagship Ventures, will join Accuri’s board of directors.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.